Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
Ji Hyun Kim, Eujin Park, Hye Sun Hyun, Myung Hyun Cho, Yo Han Ahn, Hyun Jin Choi, Hee Gyung Kang, Il-Soo Ha, Hae Il Cheong
Kidney Res Clin Pract. 2017;36(3):257-263.   Published online 2017 Sep 30     DOI: https://doi.org/10.23876/j.krcp.2017.36.3.257
Citations to this article as recorded by Crossref logo
Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome
Naye Choi, Jeesu Min, Ji Hyun Kim, Hee Gyung Kang, Yo Han Ahn
Pediatric Nephrology.2024; 39(3): 771.     CrossRef
Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome
Eugene Yu-hin Chan, Desmond Yat-hin Yap, Manuela Colucci, Alison Lap-tak Ma, Rulan S. Parekh, Kjell Tullus
Clinical Journal of the American Society of Nephrology.2023; 18(4): 533.     CrossRef
Asymmetric modulation of solar activity on tropical cyclone frequency over the western North Pacific and the possible mechanism
Delin Li, Ziniu Xiao, Jianjun Xu, Liang Zhao
Frontiers in Earth Science.2023;[Epub]     CrossRef
Rituximab Use for the Treatment of Childhood Nephrotic Syndrome by Canadian Pediatric Nephrologists: A National Survey
Cory Meeuwisse, Catherine J. Morgan, Susan Samuel, R Todd Alexander, Sara Rodriguez-Lopez
Canadian Journal of Kidney Health and Disease.2022; 9: 205435812210799.     CrossRef
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study
Eugene Yu-hin Chan, Ellen L.M. Yu, Andrea Angeletti, Zainab Arslan, Biswanath Basu, Olivia Boyer, Chang-Yien Chan, Manuela Colucci, Guillaume Dorval, Claire Dossier, Stefania Drovandi, Gian Marco Ghiggeri, Debbie S. Gipson, Riku Hamada, Julien Hogan, Kenj
Journal of the American Society of Nephrology.2022; 33(6): 1193.     CrossRef
Rituximab treatment in children with difficult-to-treat nephrotic syndrome
Gönül PARMAKSIZ
Cukurova Medical Journal.2022; 47(2): 489.     CrossRef
Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen
Eugene Yu-hin Chan, Kjell Tullus
Pediatric Nephrology.2021; 36(6): 1397.     CrossRef
Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy
Chang-Yien Chan, Sharon Teo, Liangjian Lu, Yiong-Huak Chan, Perry Yew-Weng Lau, Mya Than, Stanley C Jordan, Kong-Peng Lam, Kar-Hui Ng, Hui-Kim Yap
Translational Research.2021; 235: 48.     CrossRef
A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
Merlin Wennmann, Simone Kathemann, Kristina Kampmann, Sinja Ohlsson, Anja Büscher, Dirk Holzinger, Adela Della Marina, Elke Lainka
Frontiers in Pediatrics.2021;[Epub]     CrossRef
The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center
Young Jun Ko, Young Kyu Shim, Woo Joong Kim, Soo Yeon Kim, Hunmin Kim, Hee Hwang, Jong-Hee Chae, Ji Eun Choi, Ki Joong Kim, Byung Chan Lim
Annals of Child Neurology.2020; 28(1): 30.     CrossRef
Rituximab Use in the Management of Childhood Nephrotic Syndrome
Mahmoud Kallash, William E. Smoyer, John D. Mahan
Frontiers in Pediatrics.2019;[Epub]     CrossRef
Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome
Julien Hogan, Claire Dossier, Thérésa Kwon, Marie-Alice Macher, Anne Maisin, Anne Couderc, Olivier Niel, Véronique Baudouin, Georges Deschênes
Pediatric Nephrology.2019; 34(2): 253.     CrossRef
Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome
Fengying Wang, Xiaozhong Li, Xueming Zhu, Qing Chen, Lu Jiang, Ziqiang Zhu
BioMed Research International.2018; 2018: 1.     CrossRef